摘要
The use of polyprodrugs, which bind drugs to polymer chains through responsive linkers, is a potential technique for cancer therapy; however, a lack of endogenous triggering factors limits drug activation in tumor tissue. Herein, we rationally created a reactive oxygen species (ROS)-sensitive polyprodrug (TSCA/DOX) with cascade amplification of triggering agents and drug activation by incorporating both an ROS signal amplifier (TA(CA)) and a drug activation amplifier (SIPDOX) into a delivery system. Endogenous ROS as a triggering mechanism kicked off the initial circulation phase to increase intracellular ROS signals. Subsequently, the enhanced ROS initiated the second degradation step, allowing the polyprodrug SIPDOX to fracture spontaneously in a domino-like fashion, resulting in self-accelerated drug activation in tumor tissue. Therefore, the polyprodrug created in this study with cascade amplification of drug activation holds great promise for effective cancer treatment.
学科与关键词
- Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapyWang, Kewei; Xiao, Xuan; Liu, Ye; Zong, Qingyu; Tu, Yalan; Yuan, Youyong*Biomaterials, 2022, 289: 121803.被引 5
- A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapyLi, Jun; Zong, Qingyu; Zhao, Zhongyi; Yuan, Youyong*Chemical Communications, 2023, 59(21): 3142-3145.
- Self-amplified chain-shattering cinnamaldehyde-based poly(thioacetal) boosts cancer chemo-immunotherapyZong, Qingyu; Li, Jisi; Xiao, Xuan; Du, Xiaojiao*; Yuan, Youyong*Acta Biomaterialia, 2022, 154: 97-107.被引 13
